ESC Premium Access

Will the availability of specific reversal agents change the use of NOACs?

Congress Presentation

About the speaker

Professor Freek Verheugt

Hospital Onze Lieve Vrouwe Gasthuis, Amsterdam (Netherlands (The))
22 presentations
0 follower

3 more presentations in this session

When should I use reversal agents for NOACs?

Speaker: Professor G. Lip (Liverpool, GB)

Thumbnail

Reversal of the thrombin inhibitor dabigatran.

Speaker: Associate Professor A. Niessner (Vienna, AT)

Thumbnail

Reversal of FXa inhibitors.

Speaker: Associate Professor S. Wassmann (Munich, DE)

Thumbnail

Access the full session

Reversal of NOACs' effect: when and how?

Speakers: Professor F. Verheugt, Professor G. Lip, Associate Professor A. Niessner, Associate Professor S. Wassmann
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb